Global Oral Transmucosal Drugs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Page: 105

Published Date: 22 Jun 2021

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Oral Transmucosal Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Oral Transmucosal Drugs size is estimated to be XX million in 2021 from USD XX million in 2020, with a change of XX% between 2020 and 2021. The global Oral Transmucosal Drugs market size is expected to grow at a CAGR of XX% for the next five years.

Market segmentation
Oral Transmucosal Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Tablets
Films
Liquid Spray
Gels
Others

Market segment by Application can be divided into
Cardiovascular Disorders
Acute Pain Managements
Diabetes
Others

The key market players for global Oral Transmucosal Drugs market are listed below:
LTS Lohmann Therapie-Systeme AG
Soligenix
ZIM Laboratories Limited
Access Pharmaceutical Inc.
C.L Pharm
Cure Pharmaceutical
Aquestive Therapeutics, Inc.
NAL Pharma
IntelGenx Corp.
Eisai Co., Ltd.
Otsuka Pharmaceutical Co., Ltd.
Teva Pharmaceutical Industries Ltd.
GlaxoSmithKline plc
Viatris
Bristol-Myers Squibb Company

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Oral Transmucosal Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Oral Transmucosal Drugs, with price, sales, revenue and global market share of Oral Transmucosal Drugs from 2019 to 2021.
Chapter 3, the Oral Transmucosal Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oral Transmucosal Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Oral Transmucosal Drugs market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Oral Transmucosal Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Oral Transmucosal Drugs Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Oral Transmucosal Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
        1.2.2 Tablets
        1.2.3 Films
        1.2.4 Liquid Spray
        1.2.5 Gels
        1.2.6 Others
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Oral Transmucosal Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
        1.3.2 Cardiovascular Disorders
        1.3.3 Acute Pain Managements
        1.3.4 Diabetes
        1.3.5 Others
    1.4 Global Oral Transmucosal Drugs Market Size & Forecast
        1.4.1 Global Oral Transmucosal Drugs Sales in Value (2016-2026))
        1.4.2 Global Oral Transmucosal Drugs Sales in Volume (2016-2026)
        1.4.3 Global Oral Transmucosal Drugs Price by Type (2016-2026) & (US$/Unit)
    1.5 Global Oral Transmucosal Drugs Production Capacity Analysis
        1.5.1 Global Oral Transmucosal Drugs Total Production Capacity (2016-2026)
        1.5.2 Global Oral Transmucosal Drugs Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Oral Transmucosal Drugs Market Drivers
        1.6.2 Oral Transmucosal Drugs Market Restraints
        1.6.3 Oral Transmucosal Drugs Trends Analysis

2 Manufacturers Profiles
    2.1 LTS Lohmann Therapie-Systeme AG
        2.1.1 LTS Lohmann Therapie-Systeme AG Details
        2.1.2 LTS Lohmann Therapie-Systeme AG Major Business
        2.1.3 LTS Lohmann Therapie-Systeme AG Oral Transmucosal Drugs Product and Services
        2.1.4 LTS Lohmann Therapie-Systeme AG Oral Transmucosal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.2 Soligenix
        2.2.1 Soligenix Details
        2.2.2 Soligenix Major Business
        2.2.3 Soligenix Oral Transmucosal Drugs Product and Services
        2.2.4 Soligenix Oral Transmucosal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.3 ZIM Laboratories Limited
        2.3.1 ZIM Laboratories Limited Details
        2.3.2 ZIM Laboratories Limited Major Business
        2.3.3 ZIM Laboratories Limited Oral Transmucosal Drugs Product and Services
        2.3.4 ZIM Laboratories Limited Oral Transmucosal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.4 Access Pharmaceutical Inc.
        2.4.1 Access Pharmaceutical Inc. Details
        2.4.2 Access Pharmaceutical Inc. Major Business
        2.4.3 Access Pharmaceutical Inc. Oral Transmucosal Drugs Product and Services
        2.4.4 Access Pharmaceutical Inc. Oral Transmucosal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.5 C.L Pharm
        2.5.1 C.L Pharm Details
        2.5.2 C.L Pharm Major Business
        2.5.3 C.L Pharm Oral Transmucosal Drugs Product and Services
        2.5.4 C.L Pharm Oral Transmucosal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.6 Cure Pharmaceutical
        2.6.1 Cure Pharmaceutical Details
        2.6.2 Cure Pharmaceutical Major Business
        2.6.3 Cure Pharmaceutical Oral Transmucosal Drugs Product and Services
        2.6.4 Cure Pharmaceutical Oral Transmucosal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.7 Aquestive Therapeutics, Inc.
        2.7.1 Aquestive Therapeutics, Inc. Details
        2.7.2 Aquestive Therapeutics, Inc. Major Business
        2.7.3 Aquestive Therapeutics, Inc. Oral Transmucosal Drugs Product and Services
        2.7.4 Aquestive Therapeutics, Inc. Oral Transmucosal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.8 NAL Pharma
        2.8.1 NAL Pharma Details
        2.8.2 NAL Pharma Major Business
        2.8.3 NAL Pharma Oral Transmucosal Drugs Product and Services
        2.8.4 NAL Pharma Oral Transmucosal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.9 IntelGenx Corp.
        2.9.1 IntelGenx Corp. Details
        2.9.2 IntelGenx Corp. Major Business
        2.9.3 IntelGenx Corp. Oral Transmucosal Drugs Product and Services
        2.9.4 IntelGenx Corp. Oral Transmucosal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.10 Eisai Co., Ltd.
        2.10.1 Eisai Co., Ltd. Details
        2.10.2 Eisai Co., Ltd. Major Business
        2.10.3 Eisai Co., Ltd. Oral Transmucosal Drugs Product and Services
        2.10.4 Eisai Co., Ltd. Oral Transmucosal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.11 Otsuka Pharmaceutical Co., Ltd.
        2.11.1 Otsuka Pharmaceutical Co., Ltd. Details
        2.11.2 Otsuka Pharmaceutical Co., Ltd. Major Business
        2.11.3 Otsuka Pharmaceutical Co., Ltd. Oral Transmucosal Drugs Product and Services
        2.11.4 Otsuka Pharmaceutical Co., Ltd. Oral Transmucosal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.12 Teva Pharmaceutical Industries Ltd.
        2.12.1 Teva Pharmaceutical Industries Ltd. Details
        2.12.2 Teva Pharmaceutical Industries Ltd. Major Business
        2.12.3 Teva Pharmaceutical Industries Ltd. Oral Transmucosal Drugs Product and Services
        2.12.4 Teva Pharmaceutical Industries Ltd. Oral Transmucosal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.13 GlaxoSmithKline plc
        2.13.1 GlaxoSmithKline plc Details
        2.13.2 GlaxoSmithKline plc Major Business
        2.13.3 GlaxoSmithKline plc Oral Transmucosal Drugs Product and Services
        2.13.4 GlaxoSmithKline plc Oral Transmucosal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.14 Viatris
        2.14.1 Viatris Details
        2.14.2 Viatris Major Business
        2.14.3 Viatris Oral Transmucosal Drugs Product and Services
        2.14.4 Viatris Oral Transmucosal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.15 Bristol-Myers Squibb Company
        2.15.1 Bristol-Myers Squibb Company Details
        2.15.2 Bristol-Myers Squibb Company Major Business
        2.15.3 Bristol-Myers Squibb Company Oral Transmucosal Drugs Product and Services
        2.15.4 Bristol-Myers Squibb Company Oral Transmucosal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

3 Oral Transmucosal Drugs Sales by Manufacturer
    3.1 Global Oral Transmucosal Drugs Sales in Volume by Manufacturer (2019-2021e)
    3.2 Global Oral Transmucosal Drugs Revenue by Manufacturer (2019-2021e)
    3.3 Key Manufacturer Market Position in Oral Transmucosal Drugs
    3.4 Market Concentration Rate
        3.4.1 Top 3 Oral Transmucosal Drugs Manufacturer Market Share
        3.4.2 Top 6 Oral Transmucosal Drugs Manufacturer Market Share
    3.5 Global Oral Transmucosal Drugs Production Capacity by Company
    3.6 Manufacturer by Geography: Head Office and Oral Transmucosal Drugs Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions

4 Market Analysis by Region
    4.1 Global Oral Transmucosal Drugs Market Size by Region
        4.1.1 Global Oral Transmucosal Drugs Sales in Volume by Region (2016-2026)
        4.1.2 Global Oral Transmucosal Drugs Revenue by Region (2016-2026)
    4.2 North America Oral Transmucosal Drugs Revenue (2016-2026)
    4.3 Europe Oral Transmucosal Drugs Revenue (2016-2026)
    4.4 Asia-Pacific Oral Transmucosal Drugs Revenue (2016-2026)
    4.5 South America Oral Transmucosal Drugs Revenue (2016-2026)
    4.6 Middle East and Africa Oral Transmucosal Drugs Revenue (2016-2026)

5 Market Segment by Type
    5.1 Global Oral Transmucosal Drugs Sales in Volume by Type (2016-2026)
    5.2 Global Oral Transmucosal Drugs Revenue by Type (2016-2026)
    5.3 Global Oral Transmucosal Drugs Price by Type (2016-2026)

6 Market Segment by Application
    6.1 Global Oral Transmucosal Drugs Sales in Volume by Application (2016-2026)
    6.2 Global Oral Transmucosal Drugs Revenue by Application (2016-2026)
    6.3 Global Oral Transmucosal Drugs Price by Application (2016-2026)

7 North America by Country, by Type, and by Application
    7.1 North America Oral Transmucosal Drugs Sales by Type (2016-2026)
    7.2 North America Oral Transmucosal Drugs Sales by Application (2016-2026)
    7.3 North America Oral Transmucosal Drugs Market Size by Country
        7.3.1 North America Oral Transmucosal Drugs Sales in Volume by Country (2016-2026)
        7.3.2 North America Oral Transmucosal Drugs Revenue by Country (2016-2026)
        7.3.3 United States Market Size and Forecast (2016-2026)
        7.3.4 Canada Market Size and Forecast (2016-2026)
        7.3.5 Mexico Market Size and Forecast (2016-2026)

8 Europe by Country, by Type, and by Application
    8.1 Europe Oral Transmucosal Drugs Sales by Type (2016-2026)
    8.2 Europe Oral Transmucosal Drugs Sales by Application (2016-2026)
    8.3 Europe Oral Transmucosal Drugs Market Size by Country
        8.3.1 Europe Oral Transmucosal Drugs Sales in Volume by Country (2016-2026)
        8.3.2 Europe Oral Transmucosal Drugs Revenue by Country (2016-2026)
        8.3.3 Germany Market Size and Forecast (2016-2026)
        8.3.4 France Market Size and Forecast (2016-2026)
        8.3.5 United Kingdom Market Size and Forecast (2016-2026)
        8.3.6 Russia Market Size and Forecast (2016-2026)
        8.3.7 Italy Market Size and Forecast (2016-2026)

9 Asia-Pacific by Country, by Type, and by Application
    9.1 Asia-Pacific Oral Transmucosal Drugs Sales by Type (2016-2026)
    9.2 Asia-Pacific Oral Transmucosal Drugs Sales by Application (2016-2026)
    9.3 Asia-Pacific Oral Transmucosal Drugs Market Size by Region
        9.3.1 Asia-Pacific Oral Transmucosal Drugs Sales in Volume by Region (2016-2026)
        9.3.2 Asia-Pacific Oral Transmucosal Drugs Revenue by Region (2016-2026)
        9.3.3 China Market Size and Forecast (2016-2026)
        9.3.4 Japan Market Size and Forecast (2016-2026)
        9.3.5 Korea Market Size and Forecast (2016-2026)
        9.3.6 India Market Size and Forecast (2016-2026)
        9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
        9.3.8 Australia Market Size and Forecast (2016-2026)

10 South America by Country, by Type, and by Application
    10.1 South America Oral Transmucosal Drugs Sales by Type (2016-2026)
    10.2 South America Oral Transmucosal Drugs Sales by Application (2016-2026)
    10.3 South America Oral Transmucosal Drugs Market Size by Country
        10.3.1 South America Oral Transmucosal Drugs Sales in Volume by Country (2016-2026)
        10.3.2 South America Oral Transmucosal Drugs Revenue by Country (2016-2026)
        10.3.3 Brazil Market Size and Forecast (2016-2026)
        10.3.4 Argentina Market Size and Forecast (2016-2026)

11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Oral Transmucosal Drugs Sales by Type (2016-2026)
    11.2 Middle East & Africa Oral Transmucosal Drugs Sales by Application (2016-2026)
    11.3 Middle East & Africa Oral Transmucosal Drugs Market Size by Country
        11.3.1 Middle East & Africa Oral Transmucosal Drugs Sales in Volume by Country (2016-2026)
        11.3.2 Middle East & Africa Oral Transmucosal Drugs Revenue by Country (2016-2026)
        11.3.3 Turkey Market Size and Forecast (2016-2026)
        11.3.4 Egypt Market Size and Forecast (2016-2026)
        11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
        11.3.6 South Africa Market Size and Forecast (2016-2026)

12 Sales Channel, Distributors, Traders and Dealers
    12.1 Sales Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
    12.2 Oral Transmucosal Drugs Typical Distributors
    12.3 Oral Transmucosal Drugs Typical Customers

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Oral Transmucosal Drugs Revenue by Type, (USD Million), 2021-2026
    Table 2. Global Oral Transmucosal Drugs Revenue by Application, (USD Million), 2021-2026
    Table 3. LTS Lohmann Therapie-Systeme AG Basic Information, Manufacturing Base and Competitors
    Table 4. LTS Lohmann Therapie-Systeme AG Major Business
    Table 5. LTS Lohmann Therapie-Systeme AG Oral Transmucosal Drugs Product and Services
    Table 6. LTS Lohmann Therapie-Systeme AG Oral Transmucosal Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 7. Soligenix Basic Information, Manufacturing Base and Competitors
    Table 8. Soligenix Major Business
    Table 9. Soligenix Oral Transmucosal Drugs Product and Services
    Table 10. Soligenix Oral Transmucosal Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 11. ZIM Laboratories Limited Basic Information, Manufacturing Base and Competitors
    Table 12. ZIM Laboratories Limited Major Business
    Table 13. ZIM Laboratories Limited Oral Transmucosal Drugs Product and Services
    Table 14. ZIM Laboratories Limited Oral Transmucosal Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 15. Access Pharmaceutical Inc. Basic Information, Manufacturing Base and Competitors
    Table 16. Access Pharmaceutical Inc. Major Business
    Table 17. Access Pharmaceutical Inc. Oral Transmucosal Drugs Product and Services
    Table 18. Access Pharmaceutical Inc. Oral Transmucosal Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 19. C.L Pharm Basic Information, Manufacturing Base and Competitors
    Table 20. C.L Pharm Major Business
    Table 21. C.L Pharm Oral Transmucosal Drugs Product and Services
    Table 22. C.L Pharm Oral Transmucosal Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 23. Cure Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 24. Cure Pharmaceutical Major Business
    Table 25. Cure Pharmaceutical Oral Transmucosal Drugs Product and Services
    Table 26. Cure Pharmaceutical Oral Transmucosal Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 27. Aquestive Therapeutics, Inc. Basic Information, Manufacturing Base and Competitors
    Table 28. Aquestive Therapeutics, Inc. Major Business
    Table 29. Aquestive Therapeutics, Inc. Oral Transmucosal Drugs Product and Services
    Table 30. Aquestive Therapeutics, Inc. Oral Transmucosal Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 31. NAL Pharma Basic Information, Manufacturing Base and Competitors
    Table 32. NAL Pharma Major Business
    Table 33. NAL Pharma Oral Transmucosal Drugs Product and Services
    Table 34. NAL Pharma Oral Transmucosal Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 35. IntelGenx Corp. Basic Information, Manufacturing Base and Competitors
    Table 36. IntelGenx Corp. Major Business
    Table 37. IntelGenx Corp. Oral Transmucosal Drugs Product and Services
    Table 38. IntelGenx Corp. Oral Transmucosal Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 39. Eisai Co., Ltd. Basic Information, Manufacturing Base and Competitors
    Table 40. Eisai Co., Ltd. Major Business
    Table 41. Eisai Co., Ltd. Oral Transmucosal Drugs Product and Services
    Table 42. Eisai Co., Ltd. Oral Transmucosal Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 43. Otsuka Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
    Table 44. Otsuka Pharmaceutical Co., Ltd. Major Business
    Table 45. Otsuka Pharmaceutical Co., Ltd. Oral Transmucosal Drugs Product and Services
    Table 46. Otsuka Pharmaceutical Co., Ltd. Oral Transmucosal Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 47. Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
    Table 48. Teva Pharmaceutical Industries Ltd. Major Business
    Table 49. Teva Pharmaceutical Industries Ltd. Oral Transmucosal Drugs Product and Services
    Table 50. Teva Pharmaceutical Industries Ltd. Oral Transmucosal Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 51. GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors
    Table 52. GlaxoSmithKline plc Major Business
    Table 53. GlaxoSmithKline plc Oral Transmucosal Drugs Product and Services
    Table 54. GlaxoSmithKline plc Oral Transmucosal Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 55. Viatris Basic Information, Manufacturing Base and Competitors
    Table 56. Viatris Major Business
    Table 57. Viatris Oral Transmucosal Drugs Product and Services
    Table 58. Viatris Oral Transmucosal Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 59. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
    Table 60. Bristol-Myers Squibb Company Major Business
    Table 61. Bristol-Myers Squibb Company Oral Transmucosal Drugs Product and Services
    Table 62. Bristol-Myers Squibb Company Oral Transmucosal Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 63. Global Oral Transmucosal Drugs Sales by Manufacturer (2019-2021e) & (K Units)
    Table 64. Global Oral Transmucosal Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
    Table 65. Market Position of Manufacturers in Oral Transmucosal Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
    Table 66. Global Oral Transmucosal Drugs Production Capacity by Company, (K Units): 2020 VS 2021
    Table 67. Head Office and Oral Transmucosal Drugs Production Site of Key Manufacturer
    Table 68. Oral Transmucosal Drugs New Entrant and Capacity Expansion Plans
    Table 69. Oral Transmucosal Drugs Mergers & Acquisitions in the Past Five Years
    Table 70. Global Oral Transmucosal Drugs Sales by Region (2016-2021e) & (K Units)
    Table 71. Global Oral Transmucosal Drugs Sales by Region (2021-2026) & (K Units)
    Table 72. Global Oral Transmucosal Drugs Revenue by Region (2016-2021e) & (USD Million)
    Table 73. Global Oral Transmucosal Drugs Revenue by Region (2021-2026) & (USD Million)
    Table 74. Global Oral Transmucosal Drugs Sales by Type (2016-2021e) & (K Units)
    Table 75. Global Oral Transmucosal Drugs Sales by Type (2021-2026) & (K Units)
    Table 76. Global Oral Transmucosal Drugs Revenue by Type (2016-2021e) & (USD Million)
    Table 77. Global Oral Transmucosal Drugs Revenue by Type (2021-2026) & (USD Million)
    Table 78. Global Oral Transmucosal Drugs Price by Type (2016-2021e) & (US$/Unit)
    Table 79. Global Oral Transmucosal Drugs Price by Type (2021-2026) & (US$/Unit)
    Table 80. Global Oral Transmucosal Drugs Sales by Application (2016-2021e) & (K Units)
    Table 81. Global Oral Transmucosal Drugs Sales by Application (2021-2026) & (K Units)
    Table 82. Global Oral Transmucosal Drugs Revenue by Application (2016-2021e) & (USD Million)
    Table 83. Global Oral Transmucosal Drugs Revenue by Application (2021-2026) & (USD Million)
    Table 84. Global Oral Transmucosal Drugs Price by Application (2016-2021e) & (US$/Unit)
    Table 85. Global Oral Transmucosal Drugs Price by Application (2021-2026) & (US$/Unit)
    Table 86. North America Oral Transmucosal Drugs Sales by Country (2016-2021e) & (K Units)
    Table 87. North America Oral Transmucosal Drugs Sales by Country (2021-2026) & (K Units)
    Table 88. North America Oral Transmucosal Drugs Revenue by Country (2016-2021e) & (USD Million)
    Table 89. North America Oral Transmucosal Drugs Revenue by Country (2021-2026) & (USD Million)
    Table 90. North America Oral Transmucosal Drugs Sales by Type (2016-2021e) & (K Units)
    Table 91. North America Oral Transmucosal Drugs Sales by Type (2021-2026) & (K Units)
    Table 92. North America Oral Transmucosal Drugs Sales by Application (2016-2021e) & (K Units)
    Table 93. North America Oral Transmucosal Drugs Sales by Application (2021-2026) & (K Units)
    Table 94. Europe Oral Transmucosal Drugs Sales by Country (2016-2021e) & (K Units)
    Table 95. Europe Oral Transmucosal Drugs Sales by Country (2021-2026) & (K Units)
    Table 96. Europe Oral Transmucosal Drugs Revenue by Country (2016-2021e) & (USD Million)
    Table 97. Europe Oral Transmucosal Drugs Revenue by Country (2021-2026) & (USD Million)
    Table 98. Europe Oral Transmucosal Drugs Sales by Type (2016-2021e) & (K Units)
    Table 99. Europe Oral Transmucosal Drugs Sales by Type (2021-2026) & (K Units)
    Table 100. Europe Oral Transmucosal Drugs Sales by Application (2016-2021e) & (K Units)
    Table 101. Europe Oral Transmucosal Drugs Sales by Application (2021-2026) & (K Units)
    Table 102. Asia-Pacific Oral Transmucosal Drugs Sales by Region (2016-2021e) & (K Units)
    Table 103. Asia-Pacific Oral Transmucosal Drugs Sales by Region (2021-2026) & (K Units)
    Table 104. Asia-Pacific Oral Transmucosal Drugs Revenue by Region (2016-2021e) & (USD Million)
    Table 105. Asia-Pacific Oral Transmucosal Drugs Revenue by Region (2021-2026) & (USD Million)
    Table 106. Asia-Pacific Oral Transmucosal Drugs Sales by Type (2016-2021e) & (K Units)
    Table 107. Asia-Pacific Oral Transmucosal Drugs Sales by Type (2021-2026) & (K Units)
    Table 108. Asia-Pacific Oral Transmucosal Drugs Sales by Application (2016-2021e) & (K Units)
    Table 109. Asia-Pacific Oral Transmucosal Drugs Sales by Application (2021-2026) & (K Units)
    Table 110. South America Oral Transmucosal Drugs Sales by Country (2016-2021e) & (K Units)
    Table 111. South America Oral Transmucosal Drugs Sales by Country (2021-2026) & (K Units)
    Table 112. South America Oral Transmucosal Drugs Revenue by Country (2016-2021e) & (USD Million)
    Table 113. South America Oral Transmucosal Drugs Revenue by Country (2021-2026) & (USD Million)
    Table 114. South America Oral Transmucosal Drugs Sales by Type (2016-2021e) & (K Units)
    Table 115. South America Oral Transmucosal Drugs Sales by Type (2021-2026) & (K Units)
    Table 116. South America Oral Transmucosal Drugs Sales by Application (2016-2021e) & (K Units)
    Table 117. South America Oral Transmucosal Drugs Sales by Application (2021-2026) & (K Units)
    Table 118. Middle East & Africa Oral Transmucosal Drugs Sales by Country (2016-2021e) & (K Units)
    Table 119. Middle East & Africa Oral Transmucosal Drugs Sales by Country (2021-2026) & (K Units)
    Table 120. Middle East & Africa Oral Transmucosal Drugs Revenue by Country (2016-2021e) & (USD Million)
    Table 121. Middle East & Africa Oral Transmucosal Drugs Revenue by Country (2021-2026) & (USD Million)
    Table 122. Middle East & Africa Oral Transmucosal Drugs Sales by Type (2016-2021e) & (K Units)
    Table 123. Middle East & Africa Oral Transmucosal Drugs Sales by Type (2021-2026) & (K Units)
    Table 124. Middle East & Africa Oral Transmucosal Drugs Sales by Application (2016-2021e) & (K Units)
    Table 125. Middle East & Africa Oral Transmucosal Drugs Sales by Application (2021-2026) & (K Units)
    Table 126. Direct Channel Pros & Cons
    Table 127. Indirect Channel Pros & Cons
    Table 128. Oral Transmucosal Drugs Typical Distributors
    Table 129. Oral Transmucosal Drugs Typical Customers
List of Figures
    Figure 1. Oral Transmucosal Drugs Picture
    Figure 2. Global Oral Transmucosal Drugs Sales Market Share by Type in 2020
    Figure 3. Tablets
    Figure 4. Films
    Figure 5. Liquid Spray
    Figure 6. Gels
    Figure 7. Others
    Figure 8. Global Oral Transmucosal Drugs Sales Market Share by Application in 2020
    Figure 9. Cardiovascular Disorders
    Figure 10. Acute Pain Managements
    Figure 11. Diabetes
    Figure 12. Others
    Figure 13. Global Oral Transmucosal Drugs Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
    Figure 14. Global Oral Transmucosal Drugs Market Size and Forecast (2016-2026) & (USD Million)
    Figure 15. Global Oral Transmucosal Drugs Sales (2016-2026) & (K Units)
    Figure 16. Global Oral Transmucosal Drugs Price by Type (2016-2026) & (US$/Unit)
    Figure 17. Global Oral Transmucosal Drugs Production Capacity (2016-2026) & (K Units)
    Figure 18. Global Oral Transmucosal Drugs Production Capacity by Geographic Region: 2020 VS 2021
    Figure 19. Oral Transmucosal Drugs Market Drivers
    Figure 20. Oral Transmucosal Drugs Market Restraints
    Figure 21. Oral Transmucosal Drugs Market Trends
    Figure 22. Global Oral Transmucosal Drugs Sales Market Share by Manufacturer in 2020
    Figure 23. Global Oral Transmucosal Drugs Revenue Market Share by Manufacturer in 2020
    Figure 24. Oral Transmucosal Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    Figure 25. Top 3 Oral Transmucosal Drugs Manufacturer (Revenue) Market Share in 2020
    Figure 26. Top 6 Oral Transmucosal Drugs Manufacturer (Revenue) Market Share in 2020
    Figure 27. Global Oral Transmucosal Drugs Sales Market Share by Region (2016-2026)
    Figure 28. Global Oral Transmucosal Drugs Revenue Market Share by Region (2016-2026)
    Figure 29. North America Oral Transmucosal Drugs Revenue (2016-2026) & (USD Million)
    Figure 30. Europe Oral Transmucosal Drugs Revenue (2016-2026) & (USD Million)
    Figure 31. Asia-Pacific Oral Transmucosal Drugs Revenue (2016-2026) & (USD Million)
    Figure 32. South America Oral Transmucosal Drugs Revenue (2016-2026) & (USD Million)
    Figure 33. Middle East & Africa Oral Transmucosal Drugs Revenue (2016-2026) & (USD Million)
    Figure 34. Global Oral Transmucosal Drugs Sales Market Share by Type (2016-2026)
    Figure 35. Global Oral Transmucosal Drugs Revenue Market Share by Type (2016-2026)
    Figure 36. Global Oral Transmucosal Drugs Price by Type (2016-2026) & (US$/Unit)
    Figure 37. Global Oral Transmucosal Drugs Sales Market Share by Application (2016-2026)
    Figure 38. Global Oral Transmucosal Drugs Revenue Market Share by Application (2016-2026)
    Figure 39. Global Oral Transmucosal Drugs Price by Application (2016-2026) & (US$/Unit)
    Figure 40. North America Oral Transmucosal Drugs Sales Market Share by Type (2016-2026)
    Figure 41. North America Oral Transmucosal Drugs Sales Market Share by Application (2016-2026)
    Figure 42. North America Oral Transmucosal Drugs Sales Market Share by Country (2016-2026)
    Figure 43. North America Oral Transmucosal Drugs Revenue Market Share by Country (2016-2026)
    Figure 44. United States Oral Transmucosal Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 45. Canada Oral Transmucosal Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 46. Mexico Oral Transmucosal Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 47. Europe Oral Transmucosal Drugs Sales Market Share by Type (2016-2026)
    Figure 48. Europe Oral Transmucosal Drugs Sales Market Share by Application (2016-2026)
    Figure 49. Europe Oral Transmucosal Drugs Sales Market Share by Country (2016-2026)
    Figure 50. Europe Oral Transmucosal Drugs Revenue Market Share by Country (2016-2026)
    Figure 51. Germany Oral Transmucosal Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 52. France Oral Transmucosal Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 53. United Kingdom Oral Transmucosal Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 54. Russia Oral Transmucosal Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 55. Italy Oral Transmucosal Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 56. Asia-Pacific Oral Transmucosal Drugs Sales Market Share by Region (2016-2026)
    Figure 57. Asia-Pacific Oral Transmucosal Drugs Sales Market Share by Application (2016-2026)
    Figure 58. Asia-Pacific Oral Transmucosal Drugs Sales Market Share by Region (2016-2026)
    Figure 59. Asia-Pacific Oral Transmucosal Drugs Revenue Market Share by Region (2016-2026)
    Figure 60. China Oral Transmucosal Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 61. Japan Oral Transmucosal Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 62. Korea Oral Transmucosal Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 63. India Oral Transmucosal Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 64. Southeast Asia Oral Transmucosal Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 65. Australia Oral Transmucosal Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 66. South America Oral Transmucosal Drugs Sales Market Share by Type (2016-2026)
    Figure 67. South America Oral Transmucosal Drugs Sales Market Share by Application (2016-2026)
    Figure 68. South America Oral Transmucosal Drugs Sales Market Share by Country (2016-2026)
    Figure 69. South America Oral Transmucosal Drugs Revenue Market Share by Country (2016-2026)
    Figure 70. Brazil Oral Transmucosal Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 71. Argentina Oral Transmucosal Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 72. Middle East & Africa Oral Transmucosal Drugs Sales Market Share by Type (2016-2026)
    Figure 73. Middle East & Africa Oral Transmucosal Drugs Sales Market Share by Application (2016-2026)
    Figure 74. Middle East & Africa Oral Transmucosal Drugs Sales Market Share by Country (2016-2026)
    Figure 75. Middle East & Africa Oral Transmucosal Drugs Revenue Market Share by Country (2016-2026)
    Figure 76. Turkey Oral Transmucosal Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 77. Egypt Oral Transmucosal Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 78. Saudi Arabia Oral Transmucosal Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 79. South Africa Oral Transmucosal Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 80. Sales Channel: Direct Channel vs Indirect Channel
    Figure 81. Methodology
    Figure 82. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

LTS Lohmann Therapie-Systeme AG
Soligenix
ZIM Laboratories Limited
Access Pharmaceutical Inc.
C.L Pharm
Cure Pharmaceutical
Aquestive Therapeutics, Inc.
NAL Pharma
IntelGenx Corp.
Eisai Co., Ltd.
Otsuka Pharmaceutical Co., Ltd.
Teva Pharmaceutical Industries Ltd.
GlaxoSmithKline plc
Viatris
Bristol-Myers Squibb Company

Related Reports

Global Oral Transmucosal Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Global Oral Transmucosal Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

date 17 Jan 2022

date Pharma & Healthcare

Global Oral Transmucosal Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Oral Transmucosal Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 10 Jan 2023

date Pharma & Healthcare

Oral Transmucosal Drugs

Global Oral Transmucosal Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 10 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Oral Transmucosal Drugs market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Global Oral Transmucosal Drugs Supply, Demand and Key Producers, 2024-2030

Global Oral Transmucosal Drugs Supply, Demand and Key Producers, 2024-2030

date 02 Mar 2024

date Pharma & Healthcare

The global Oral Transmucosal Drugs market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

oral transmucosal drugs

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>